EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Validation of an LC–HRMS Method for Quantifying Indoxyl Sulfate and p-Cresyl Sulfate in Human Serum

María Rodríguez-García, Irene Martínez, Irene Aliart, Jaime I Sainz de Medrano iD, Nayra Rico iD, Víctor Joaquín Escudero-Saiz iD, Francisco Maduell iD, Manuel Morales-Ruiz iD, Gregori Casals iD

Molecules · 08.02.2025 · 30 (4) · 782

DOI: 10.3390/molecules30040782 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Molecules, online erschienen am 08.02.2025. Verfasst von María Rodríguez-García und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Genetics Department, CDB, Hospital Clínic of Barcelona, 08036 Barcelona, Spain. Hauptthemen laut MEDLINE: Indican, Sulfuric Acid Esters, Cresols, Mass Spectrometry. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Agencia Estatal de Investigación, FEDER, European Union, “A way of making Europe”; Agencia Estatal de Investigación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate quantification of indoxyl sulfate (IndS) and p-cresyl sulfate (pCS) is essential for understanding their role in chronic kidney disease (CKD) progression and for developing strategies to mitigate their harmful effects, including cardiovascular morbidity and renal fibrosis. Advances in liquid chromatography–high-resolution mass spectrometry (LC–HRMS) enable the integration of powerful diagnostic tools into clinical laboratories. Along with accurate quantification, precise mass measurements allow for untargeted compound identification.

Methods

An LC–HRMS was validated for quantifying IndS and pCS in human serum, following EMA guidelines. The method involved protein precipitation with methanol, micro-LC for chromatographic separation, and detection based on accurate mass, with simultaneous high-resolution full-scan acquisition. Clinical samples from patients with varying degrees of renal insufficiency and samples obtained before and after hemodiafiltration were analyzed.

Results

The method demonstrated acceptable linearity, precision, and accuracy. The measurement range for both analytes was from 100 to 40,000 ng/mL. Serum levels of IndS and pCS correlated with decreased renal function. After hemodiafiltration, there was a significant reduction of IndS (50%) and pCS (43%). Simultaneous untargeted analysis allowed to identify metabolites significantly underexpressed after hemodiafiltration.

Conclusions

An accurate LC–HRMS method was validated for the quantification of IndS and pCS serum levels in patients with CKD, providing insights into toxin dynamics and enabling untargeted metabolic evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndicanSulfuric Acid EstersCresolsMass SpectrometryHumansChromatography, LiquidRenal Insufficiency, ChronicReproducibility of ResultsMale

Stichwörter der Autor:innen

chronic kidney diseasehemodiafiltrationhigh-resolution mass spectrometrymetabolomicsmicro-liquid chromatographyuremic toxins

Substanzen

IndicanSulfuric Acid Esters4-cresol sulfateCresols

Autor:innen und Institutionen

  • Biochemistry and Molecular Genetics Department, CDB, Hospital Clínic of Barcelona, 08036 Barcelona, Spain.
  • Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, 08036 Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelons, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 28029 Madrid, Spain.
  • Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, 08036 Barcelona, Spain.
  • Department of Fundamental and Clinical Nursing, Faculty of Nursing, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.

ORCID-Profile: Jaime I Sainz de Medrano, Nayra Rico, Víctor Joaquín Escudero-Saiz, Francisco Maduell, Manuel Morales-Ruiz, Gregori Casals

Förderung

  • Instituto de Salud Carlos III
  • Agencia Estatal de Investigación
  • FEDER, European Union, “A way of making Europe”; Agencia Estatal de Investigación
  • Universitats de la Generalitat de Catalunya

Zitieren

APA

Rodríguez-García, M., Martínez, I., Aliart, I., Sainz de Medrano, J. I., Rico, N., Escudero-Saiz, V. J., Maduell, F., Morales-Ruiz, M., & Casals, G. (2025). Validation of an LC–HRMS Method for Quantifying Indoxyl Sulfate and p-Cresyl Sulfate in Human Serum. Molecules, 30(4), 782. https://doi.org/10.3390/molecules30040782

Vancouver

Rodríguez-García M, Martínez I, Aliart I, Sainz de Medrano JI, Rico N, Escudero-Saiz VJ, et al. Validation of an LC–HRMS Method for Quantifying Indoxyl Sulfate and p-Cresyl Sulfate in Human Serum. Molecules. 2025;30(4):782. doi:10.3390/molecules30040782

BibTeX
@article{RodrguezGarca2025,
  author = {Rodríguez-García, María and Martínez, Irene and Aliart, Irene and Sainz de Medrano, Jaime I and Rico, Nayra and Escudero-Saiz, Víctor Joaquín and Maduell, Francisco and Morales-Ruiz, Manuel and Casals, Gregori},
  title = {Validation of an LC–HRMS Method for Quantifying Indoxyl Sulfate and p-Cresyl Sulfate in Human Serum},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {4},
  pages = {782},
  doi = {10.3390/molecules30040782}
}
Kostenlos starten →